Literature DB >> 1846459

Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients.

R Hrebinko1, M L Jordan, J S Dummer, D P Hickey, R Shapiro, C Vivas, T E Starzl, R L Simmons, T R Hakala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1846459      PMCID： PMC2964081     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

1.  Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.

Authors:  R L Simmons; A J Matas; L C Rattazzi; H H Balfour; J R Howard; J S Najarian
Journal:  Surgery       Date:  1977-11       Impact factor: 3.982

2.  Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies.

Authors: 
Journal:  N Engl J Med       Date:  1986-03-27       Impact factor: 91.245

3.  Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.

Authors:  D R Snydman
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

4.  Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection.

Authors:  C V Paya; P E Hermans; T F Smith; J Rakela; R H Wiesner; R A Krom; V E Torres; S Sterioff; C J Wilkowske
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

5.  A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.

Authors:  H H Balfour; B A Chace; J T Stapleton; R L Simmons; D S Fryd
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

6.  Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.

Authors:  P K Peterson; H H Balfour; S C Marker; D S Fryd; R J Howard; R L Simmons
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

7.  Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients.

Authors:  M A Harbison; P C De Girolami; R L Jenkins; S M Hammer
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

8.  Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.

Authors:  S C Marker; R J Howard; R L Simmons; J M Kalis; D P Connelly; J S Najarian; H H Balfour
Journal:  Surgery       Date:  1981-06       Impact factor: 3.982
  8 in total
  3 in total

1.  Rapid cytomegalovirus pp65 antigenemia assay by direct erythrocyte lysis and immunofluorescence staining.

Authors:  S K Ho; C Y Lo; I K Cheng; T M Chan
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 3.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.